Selank
Investigational in U.S.A synthetic peptide developed in Russia and studied for anxiolytic and cognitive effects, with a limited Western clinical evidence base.
The Peptide Index — Evidence, Community Signal & Regulatory Status | BIOHACKING. EVOLVED.
Cognition includes attention, memory, executive function, mood, stress response and subjective mental clarity. These outcomes overlap, but they are not interchangeable—and an anxiolytic or mood effect should not automatically be labeled a nootropic effect.
Subjective focus, reduced anxiety, memory performance and executive function are different endpoints. The evidence should say which one actually changed.
The word “cognition” can hide very different biological and psychological outcomes. Separating them makes the evidence much easier to judge.
Neuropeptide interest is high, but accessible high-quality human evidence is uneven and often formulation-, population- or geography-specific. Selank is the clearest example of why “promising” should not become “proven.”
A synthetic peptide developed in Russia and studied for anxiolytic and cognitive effects, with a limited Western clinical evidence base.
An endogenous peptide hormone and established drug in obstetric medicine, also widely studied in social, behavioral and metabolic neuroscience.
A small peptide historically studied in sleep and stress biology, with inconsistent and limited human evidence.
A peptide that activates the reproductive hormone axis and has been studied in humans for fertility and neuroendocrine applications.
Evidence scores are editorial orientation, not cognitive-performance rankings. Anxiety, mood, sedation and sleep effects should not be automatically reclassified as cognitive enhancement.
Selank and related neuropeptide discussions often combine anxiety relief, subjective focus and cognitive enhancement into a single story. Community reports can be useful for tracking what people notice—but they are especially vulnerable to expectation effects and endpoint drift.
Cognitive performance is shaped by sleep, stress, cardiovascular health, metabolic health, psychiatric health, training and environment as much as by any single molecule.
Future coverage can follow sleep architecture, stress physiology, neuroimaging, digital cognitive testing, stimulants, psychiatric therapeutics, wearables, brain-computer interfaces and evidence-based behavioral interventions.
High community interest around calm focus and anxiety, with a human evidence base that should be interpreted carefully.
A useful reminder that names and mechanisms can sound more definitive than the underlying human evidence.
Sleep quality, sleep architecture and next-day cognition are deeply linked—but distinct outcomes.
Compare Human Evidence, Community Signal, The Gap and regulatory status across the broader library.